Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Don't ignore this quality company. It is undervalued - the only question is how quickly that value will be unlocked and reflected in the share price.
My Christmas gift to whoever is out there is to tell you to buy as much as you can of this stock on Monday morning. Next Christmas you can thank me profusely when you've made at least 200% over your basis, and that's a lowball estimate.
This has just capped off a great week. In the long run this will trade much higher than what it is trading at now.
I feel as though this is very undervalued with its market cap being what it is now compared with the potential of its pipeline. This will be much bigger than what it is currently being given credit for.
I like the nice, gradual, consistent rise in the share price. I think there is no way to lose money here, and I think the gains will be very substantial over the next two to three years.
Nice news today - this is going to be a very successful company in the not-too-distant future.
I feel like people are sleeping on this one. It was a major shock from which to recover to have the CEO and half of the board resign, but I think Michael Amoroso knows what he is doing and is doing a good job in moving the company forward, and I believe that there is good long-term potential here.
Good news and a nice increase today. This well-managed company has really good long-term potential.
Another day, another 12% increase in the share price. Ho hum.
That's great! You must be very happy with all of those. Can you imagine what will happen here with the relatively low outstanding shares when more people actually know that this exists and realize what they have here?
I bought my first tranche at $7.36 on Monday. It closed today at $14.26. I'm a happy Acuity holder. The best part is that I believe this is just the beginning of a long and consistent rise in the share price. I really do hope others join us here soon.
All I can say is WOW. I can't even imagine what will happen when this becomes popular after it is listed in the U.S. next year and begins to receive analysts' attention. The limited shares outstanding makes me think of something like a champagne bottle opening.
I don't care about changing your mind. I really couldn't care less what you think of the company. I'm not trying to convince other people about the company either. I'm stating what's going on here based on my interpretation of the facts that are publicly available. The share price is much too high right now to buy it. I'd buy if it ever hits $4.00 again, but probably not before. There are many other stocks out there that currently have a better risk/reward profile than this does, and I'm buying them.
I'm not sure in what way it is recognizable, but it is interesting that you think so. We should agree to disagree. Oddly enough, I haven't invested in this yet - I was thinking about it at $3.70, as Ultragenyx clearly knew what they were doing putting in $40 million at $5.11, but I thought I had more time before they developed further. The $90 million investment at $3.70 changed the whole game, and now the floor is clearly $3.70 unless they have a developmental mishap. I think it's overpriced right now, but when the flurry of activity dwindles and it slowly sinks back toward $4.00 assuming the absence of any major near-term news, I could be very interested in getting in dependent on their future progress.
I'm in again this morning with the proceeds from selling one of my biopharma stocks that I think has really good potential, so to sacrifice that to buy this shows how I feel about this company. I truly believe that I won't see another opportunity like this for a long time, if ever.
The impression you should be getting is that of a person who knows how to analyze publicly-available information and make informed conclusions. I've seen more POS stocks in my investing experience on these boards of the type with which you are apparently familiar than I can count, and I can tell you that this is not one of them.
To think that this is only scratching the surface of where this is going and that I've made over 47% in just two days of owning this stock boggles my mind.
I totally agree with your analysis.
On what information do you base your allegations? Have you read the publicly-available information? By rule of logic then, the reverse scamming must have pulled it up to over $6 so far today.
I really feel like we're sitting on Netflix when it was at $15. I think it will be exciting when others figure it out and join us here.
Nice movement today. I really like this one in the long-term.
It's going to be fun looking back at these first few posts when this hits $50. The only question is when, not if.
Another good day for the home team - I think the deserved upward movement of the share price is finally building momentum.
I got in at $7.36 almost at the opening, and was up 28% at last check. I think we'll both be very happy here in a couple of years. Once people realize what I think they have here, I feel as though it's dynamite, because they have no analyst following, they're only listed in Canada, and the outstanding shares are so low. If they get listed in the U.S. next year and begin to have some analysts following them coupled with marketplace acceptance of Illumin, the low share count should send this up like a rocket with the demand that will generate. Just look what this morning's announcement did to the demand!
They have to sell shares to finance the company's development - do you really think knowledgeable investors would invest $90 million at $3.70 per share if they didn't see something worth investing in here? As someone said in some old movie - follow the money.
I feel like this is the next TradeDesk. I hope very few others think so, because I'm going in tomorrow morning with a significant position. This could define disruptive technology.
Definitely a good strategy. I would have sold out too if I had bought on Thursday at $3.70 as I should have.
If it is, it's only temporary. I like this one, as its pipeline has a large addressable population and it is supported by quality investors. I'm in at $7.15, and will happily buy anywhere around $7.00.
There's $90 million of capital that just went into this that doesn't think it's a pumping scam. The people behind that infusion are more knowledgeable than you or I with regard to what's going on at this company.
I love this stock - I see very good things happening to the share price within the next year.
That's because people are afraid of the potential dilution from the $100 million stock filing. All I can say is that if Manny Lichtman was willing to pay $3.25 for this back in the spring, I have confidence in buying anywhere below that, and I believe they have a pipeline that will prove to be worth far more than where it is trading now in a couple of years.
This is a screaming double from here and maybe a four-bagger within a year. All of my available incoming capital is going here for the foreseeable future. All we have to do is wait for people to put the pieces together, and I have a feeling it won't be long now.
I like yesterday's jump - maybe people are finally beginning to get a clue about what the real value of this is.
I guess I would have only had to wait a week. I didn't pull the trigger in time, and it cost me a 50% profit. I thought I had much more time, and didn't expect news like that. It's clear that the floor is now $3.70, and when the euphoria subsides and it slides gradually down again towards that if there is no further news, it'll be buying time anywhere close to that and under $5.11 where Ultragenyx got in. I like this one long-term, especially after $90 million more of infused capital says it's going places.
Nice movement on Friday in terms of price and volume - maybe people are beginning to get the idea that this is undervalued at this level.
That's good to know - I think my available investment capital will be directed here for some time to come.
The fact that an executive of Jack Bailey's caliber came to this company to lead it is primarily what led me to take a position. He wouldn't waste his time that way if he didn't see tremendous potential in the pipeline and the people. I'll be adding to my position as long as the price stays as low as it is.
When I invest in small cap biotechs, I have a three-year time frame in mind. The appeal of this type of stock to me is seeing something that others don't and being able to assess whether they've got technology that will eventually generate discounted cash flows that aren't yet fully reflected in the share price. In this case, Ultragenyx seems to have done that for me, as they specialize in this sort of thing.
Which is why I'll be happy to buy at $3.70 when some investment capital frees up if they were willing to pay $5.11. They know something I don't.